!"#$% (Suppl 6): !"OMMQ!"#$%&'()*+, TRKSV!" #$%&'( )*VRT=xPz!"#$%&'()*+,-./0 UMB

Size: px
Start display at page:

Download "!"#$% (Suppl 6): !"OMMQ!"#$%&'()*+, TRKSV!" #$%&'( )*VRT=xPz!"#$%&'()*+,-./0 UMB"

Transcription

1 =!"#$!"#$% N!"#$%&'()*!" N!"#$%&'()*+,-.$/ $()*789: ;< 18 (Suppl 6):35-40!!"#$%!&'()*+,!"#EjóÅçÄ~ÅíÉêáìã=íìÄÉêÅìäçëáëF!"#$%&'()*+,-&'(./0 NJR=ã!EÇêçéäÉí=åìÅäÉáF!"#$%&!"#$%&'(xNz!!"#$%&'()!*+,-OM!"#$%&'()*+,-./0-1!"#$%&'() OMMS!" VMM!"#$%&' OMM!"#$% UMB!"#$%&'()*+,*xOz!"!"#$%&'()*+,-./ NRIMMM!"OMMQ!"#$%&'()*+, TRKSV!"#$%&'()*VRT=xPz!"#$%&'()*+,-./0 UMB!"#xQz!NVUM!"#$%&!"#$%&'()NVVM!"#$%!"#$%xQIRz!"#$%&'()!"#$%&'()*#+,-)*#.!"#$%EefsF!"#$%&'()!"#$%&'()*+,-.*#/!"#$%&'()*$$%+,-.$$!"#$%&'()*QMMM!"#$ NLP!"#$%&'()*+,-.#$(/!"#$%&'()*+,-.)/01!"#$%&'()*$+xSz!"#$%&'()*+,-./01!"#$%&'()*+,-./01 O!"#$%&'()*!" Tzu Chi Med J (Suppl 6)! PR

2 !"#$%&'()*+ O RM xtiuz!"#$%&'()*+,-+'.+,/!"#$%&'()*+,-./0123!"#$%&' ()*' +,-. xvz!"#$$%& QMB RMB!"#$% S!"#$%&'()!"!#$%&'(OT QQ!"#$ xnminnz!"#$%&'()*+,-./!"#$%&'( )*+,-!"./0!"#$%"&'()*+,-.$/*+!"#xRz!"#$%&'()*+,-./0!!"#$%&'(OMMP!"#$%#!"#$%&'(!)*+,-./012!"#$%&'()"*+,-./01!"#$%&'()*+,-./01"2!"#$% SM!"#$%&'#$ EON F!"#$%&'()$*+,!"#$%&'()*+,"#-./E TMBF!"#$E UBFxNOz!"#OMMO P OMMP NN!! NV!"#$%&'()*+,!"#$%&'()*+,-./012! NU!"#$%& '()*+, NRO!"#$%&'()*+,-./0 "!"# u!"#$%&'()*+, NNU!"#$%&'()*+,-.! UM ETMKNUBF!"#$%&'EåçåJíìÄÉêÅìJ äçëáë=ãóåçä~åíéêáìãi=kqjf!"t ESKNQBF!"xNPINQz!"#$!"#$%&'()*+,-./#0 E~Çãáåáëíê~íáîÉ=ÅçåíêçäëF!"#EÉåîáêçåãÉåí~ä ÅçåíêçäëF!"#$EêÉëéáê~íçêó= éêçíéåíáçå ÅçåíêçäëF!"#$%&'(!)*+,-./ xnrjntz!!"#$%&'()*+,-../0!"#$%&'()*+,-./0123 PS!!"#$%&'()*+,-./ 0!"#$%&'()*+",-.%/01!"#$%&'()*+,'-./012!" #$%&'()*+,-(./)!"#$%&'()* NK=!"#$%&'()*+,-./012!"#$%&'()*!'()*+,!"#$%&'()$*#+,-./!"#$%&!'()*&!"#$%&'()*+,-./012!" OK=!"# $!"%&'()*+,!"#$%&'()*+!"#$%&'!"#$%&'()*+,-./0!"#$%&'()*+,-$%&./!"#$%&'()*&()+),)!"#$ %&'()*+,-./01 PK=!"#$%&'()*+,-!"!"#$%&'()*+,-./01!"#$%&'()*+,-./012!"#!"#$% &'()!xnuz QK=!"#$%&'()*+,-./!"#$"%&'()*+,RK=!"#$%&'()*+,!-.!"#$%&'()*+,-./-01!"#$ %& '()*+,-. /!"#$%&'()xnsjnuz!"#! "#$%&'()*+,-./01!"# SK=!"#$%&'()* TK=!"#$%&'()*+,-./$01!"#$ %"&' %"(!"#$%&'()*+,-.'($*! UK=!"#$%&'()*+,-./01+!"#$%&'()*!+,-.!"#$%&'()*+,-./012!"#$%&'(!)*+,-./ 0!"#$%&'() u!" VK=!"#$%&'( NMK=!"#$%&' Tzu Chi Med J (Suppl 6)

3 =!"#$!!"#$%&'()*+,-./01!"#$%&'(&)*+,-./012!"#$%&'()*+,-./0123!"#$%&'()*+,$-./012!"#$$%&'()*+,-.(/0$!"#$%&'()*+*,-.!"#$%&'()*+,-EäçÅ~ä=ÉñJ Ü~ìëí=îÉåíáä~íáçåF!"EÖÉåÉê~ä=îÉåíáä~íáçåF!"#$EÜáÖÜJÉÑÑáÅáÉåÅó=é~êíáÅìä~íÉ=~áêF =Eìäíê~îáçäÉí=ÖÉêãáÅáÇ~ä=áêê~Çá~íáçåI=rsdf=F!"#$%&'()*+"#,-./01!"#$%&'#()*+,!"#!"#$%&' ()xnrjomz!"#!"#$%&'()*+,-./01!"#$%&'$ ()*+,-./0!"#$%&'()*+,-./012!"#$%&'()*+,-./0#12!"#$%&'()*+,-./012'!"#$%&'()*+,!!"#$%&'()*+,-./01!"#$%&'$()*+#$,"-./ E~áêÄçêåÉ=áåÑÉÅíáçå=áëçä~íáçå=êççãF!"#$%!"#$%&'()*+,-./01 2!"#$%&'()*+,-./0#1*!"#$%&'!()*+,!! "#$ %&%"'()*+,-./!"#$%&'()*+,-. /0!"#$%& '() *+,-. OKR=m~ EMKMN!F xnrjomz!"#$%&'!"#$%&'()*+,-./0123!"#$%&'()*+,-./01e~áê ÅÜ~åÖÉë=éÉê=ÜçìêI=^`eFxNRINUIOMz!"#$%&!"#$%&'()*+,-./0123!"#$%&'()*"+#,-./01!"#$%&'()*+&,-./012!"#$%&'()*&+,-./012!"#$%&'()*+,-./0123!"#$%&'()*+,-./&01! rsdf!"#$%&'()*+, Tzu Chi Med J (Suppl 6)!"#$%&'()*+,-./0123!"#$%&'()*!"#$EÜáÖÜJÉÑÑáÅáÉåÅó=é~êíáÅìä~íÉ=~áêI ebm^f!"#$%&'!"()*+,-./ MKP= ã!" #$%&'() VVKVTB!" #$%&'() N= ã R= ã!"#$%&'( )*+!,-./0 xnrinuz!"#$%&'()*+,!"#$%&'()*+,-./0123!"#$%&'()*+ "#$,-.+!"#$%&'()'*+,-./0%!"#$%&'"(!"Eìäíê~îáçäÉí=ÖÉêãáÅáÇ~ä=áêê~Çá~íáçåI=rsdfF!"#$%&'()*+,-.%)/!"#$%&'!()*+ VRB!" ORPKT=åã!"#$%xONz!"#$!"#$%&'(!EÇìÅí=áêê~Çá~íáçåF!"#EìééÉêJ~áê=áêê~Çá~íáçåF!"#$% xnrinuz!eçìåí=áêê~çá~íáçåf!"#$%&'!"#$%&'()*+,-./.0(1!"#$%&'()*+,-./0123!"#$%&'()*+,-./012+!"#$%&'()*+,-./0!"#$%&'()*+,-./0123!"#$%&'()*+,-./0123!"!"#$%=eìéééêj~áê=áêê~çá~íáçåf!!"#$%&'()*+,-./0123!"#$%&'() U EORM F!"#$%&'() *+,-."#/%!"#$%&xnrinuionz!"#$%&!"#$%&'()*+,-./01!"#$%&'()* +,-./01!"#$%&'()*+,-./0123!"#$%&'()*+,-./,.0$!"#$%&'(!"#$%&'!"#$%&(!"#$%&'()*+,-./0 12!"#$%&'()*+,-.'/ 01! PT

4 !"!"#$%&'()*+,-./01!"#$%&'()*+,-./012!"ENF!"#$%&'()*+,( EOF!"#$%&'()*+,-.!)!"#$%&'(EPF!"#$%&'!"#$%&'()*+,-./0123!"#$%&'() kvr!" VRB MKP ã!"#$!"#$% &'()*+,-./)01!"#$ kvr!"#$%&'(!"#$ kvr!"#$%&'()*!xooz!"#$%&'()*+,-./01!"#$%&'()*+,-./0123!"#$%&'()*+$%,-./01!"#$%&'()*+,-./!0"!"#$%&'()*+!"#!"#$%&'()*+,-./01!"#$%&'()*+,-./0123!"#$%&'()*+,-./0123!"#$%&'(%)*+,-./ 01 m`o!"#$%&'()*+,-./!"#$!"#$%&'()*+,-.'/0!"#$% T= NS= xopz!"#$%!"#$%&'()*+,-./$012!"#$%&'()*+,-./012!"#$%&'()*+,-./012!"#$% &'()*+,-./01!"#$%&'()*+,-./$01(!"xOQIORz!"#$%&'()*+!"#$%&'()*+,-./0123!"#$%&'()*+,-./0123!"#!"#$% fëçåá~òáç= =oáñ~ãéáåáå!"#$%&'(!"#$% fëçåá~òáç= =oáñ~ãéáåáå!!"#$% &'()*+,-./01&!"#$%&'()*+,-./+0/1!"#$%&'#()*+QB=xOUz!!"#$%!&'() OBxOVz!"#!"#$%&'()*+,-.+/0!"#$%&'()*#+,-./01!"#$%&' ()*+$%,-./0!"#$%&'()*+,-!"./01!"#$%&'()*!"#$%&'()*!"#$%&'()*+,-./01! "#$%& '()*+,-./01!"#$%&'ENF!"#$%&'(!"#EOF!"#$%&'()"*+!"#$%&'()*EPF!"#$%!"#$%&'()*+,-./!"#$%&= i~íéåí=q_=áåñéåíáçå!"#!"#$%&'()*+,-./01!"#$%&'()*+,-./"#$0 xpmipnz!"#$%&'()*+,'!"#$%&'()*!+,-./012!"#$%&'()*+,-./0123 Eca^F OMMR!"#$%&'()E_äççÇ ~ëë~ó= Ñçê= jóåçä~åíéêáìã= íìäéêåìäçëáëi= _^jqf nì~åíácbolk=q_=íéëí!"#$%&'()*! Tzu Chi Med J (Suppl 6) PU!"#$%&'()*+, VR Q!"#$NNITRN!"#$%&xOSz!"#$%&'()*+",#$-./!"#$%&'()*+,--./0!"#$%&'()*+,-#$./01!"#$%&'()*+,-. /0$%!"#$%&'()*+,! -.!"#$%&'()*+,#-./012!"#$ %&'()*+,-./01!"#$%&'()*+,-./01!!"#$%&'()*+,-./01xOTz

5 =!"#$!" kqjxpoz!"#$%&'()!"#$%&'()*+,-./0!"#$%&'()*+"#$%,+!"#$%$&'()*+,-./012!"#$%&'()*+,-./0#12!"#$%%&'() *+,-./()!"#$%&'()*+,-./0#12!"#$%&'()*+,-./012!"#$%&'()*+,-.! 1. Diagnostic standards and Classification of Tuberculosis in Adult and Children. Am J Respir Crit Care Med 2000; 161: World Health Organization : Global tuberculosis control: surveillance, planning, financing. WHO Geneva 2006, World Health Organization, 2006, pp !"#$%&'()*+,-./% !VP!"#$%&'()* 2005pp Sepkowitz KA: Tuberculosis and the health care worker: A historical perspective. Ann Intern Med 1994; 120: Menzies D, Fanning A, Yuan L, Fitzgerald M: Tuberculosis among health care workers. N Engl J Med 1995; 332: World Health Organization: Guidelines for implementing collaborative TB and HIV programme activities WHO report, 2003, pp Kilinc O, Ucan ES, Cakan MDA, et al: Risk of tuberculosis among healthcare workers: Can tuberculosis be considered as an occupational disease? Respir Med 2002; 96: Jelip J, Mathew GG, Yusin T, et al : Risk factors of tuberculosis among health care workers in Sabah, Malaysia. Tuberculosis 2004; 84: Toman's tuberculosis case detection, treatment, and monitoring 2nd edition World Health Organization Geneva, 2004, pp MacGregor RR: A year's experience with tuberculosis in a private urban teaching hospital in the postsanatorium era. Am J Med 1975; 58: Craven RB, Wenzel RP, Atuk N: Minimizing tuberculosis risk to hospital personnel and students exposed to unsuspected disease. Ann Intern Med 1975; 82: Centers for Disease Control and Prevention (CDC): Nosocomial transmission of Mycobacterium tuberculosis found through screening for severe acute respiratory syndrome-taipei, Taiwan, MMWR Recomm Rep 2004; 53: !"#$%&'()*%+,-.)*%/ !"#$!"%&'()*+,-./012345!"#$%&'()*+,-.=!=2005; 21: Jensen PA, Lambert LA, Iademarco MF, Ridzon R: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, MMWR Recomm Rep 2005; 54: American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America: Controlling tuberculosis in the United State. Am J Respir Crit Care Med 2005; 172: Davis YM, McCray E, Simone PM: Hospital infection control practices for tuberculosis. Clin Chest Med 1997; 18: !"#$%&'()*+,-./%0123$4* CDC: Tuberculosis Coalition for Technical Assistance. International Standard for Tuberculosis Care. The Hague: Tuberculosis Coalition for Technical Assistance, CDC: Guidelines for Environmental Infection Control in Health-Care Facilities Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52: Russell AD, Hugo WB, Ayliffe GAJ: Principles and practice of disinfection, preservation and sterilization. 4nd ed. London: Blackwell Scientific Publications, 2004, pp American National Standard Institute. American national standard for respiratory protection. ANSI Z New York: American National Standards Institute, Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH: Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: Newberry WM, Sanford JP: Defective cellular immunity in renal failure: Depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 1971; 50: Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH: Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: !"#W= =E!F tw/index_info_info.asp?data_id= Dooley SW Jr, Castro KG, Hutton MD, Mullan RJ, Polder JA, Snider DE Jr: Guidelines for preventing the transmission of tuberculosis in health care settings, with special focus on HIV-related issues. MMWR Recomm Rep 1990; 39:1-29 Tzu Chi Med J (Suppl 6)! PV

6 28. World Health Organizer: Drug- and multidrug-resistant tuberculosis (MDR-TB). dotsplus/faq/en/index.html., !"#$%&'()*+,-./012!" OMMS 30. American Thoracic Society, CDC: Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49(RR06): Snider DE Jr, Caurthen GM: Tuberculin skin testing of hospital employees: Infection, "boosting," and two-step testing. Am J Infect Control 1984; 12: Mazurek GH, Jereb J, Lobue P, et al: Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United State. MMWR Recomm Rep 2005; 54: QM! Tzu Chi Med J (Suppl 6)

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1

More information

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Emergency Department and Receiving Areas CHAPTER 24: Author P. Suri, MD R. Gopaul, MD

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Emergency Department and Receiving Areas CHAPTER 24: Author P. Suri, MD R. Gopaul, MD GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 24: Emergency Department and Receiving Areas Author P. Suri, MD R. Gopaul, MD Chapter Editor Gonzalo Bearman MD, MPH, FACP, FSHEA, FIDSA Topic Outline

More information

Peggy Leslie-Smith, RN

Peggy Leslie-Smith, RN Peggy Leslie-Smith, RN EMPLOYEE HEALTH DIRECTOR - AVERA TRAINING CONTENT 1. South Dakota Regulations 2. Iowa Regulations 3. Minnesota Regulations 4. Interferon Gamma Release Assay (IGRA)Testing 1 SOUTH

More information

Please evaluate this material by clicking here:

Please evaluate this material by clicking here: EPI Case Study 3: Cross-Sectional, Case-Control, and Cohort Studies Identification of TB Risk Time to Complete Exercise: 60 minutes LEARNING OBJECTIVES At the completion of this module, participants should

More information

Risk of Tuberculin Conversion According to Occupation among Health Care Workers at a New York City Hospital

Risk of Tuberculin Conversion According to Occupation among Health Care Workers at a New York City Hospital Risk of Tuberculin Conversion According to Occupation among Health Care Workers at a New York City Hospital JOYCE LOUTHER, PEDRO RIVERA, JOSEPH FELDMAN, NORIEDA VILLA, JACK DEHOVITZ, and KENT A. SEPKOWITZ

More information

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Tuberculosis and Diabetes Mellitus Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Learning Objectives Understand the impact of uncontrolled diabetes mellitus (DM) on TB infection

More information

EPI Case Study 2: Reliability, Validity, and Tests of Agreement in M. Tuberculosis Screening Time to Complete Exercise: 30 minutes

EPI Case Study 2: Reliability, Validity, and Tests of Agreement in M. Tuberculosis Screening Time to Complete Exercise: 30 minutes EPI Case Study 2: Reliability, Validity, and Tests of Agreement in M. Tuberculosis Time to Complete Exercise: 30 minutes LEARNING OBJECTIVES At the completion of this Case Study, participants should be

More information

Detecting latent tuberculosis using interferon gamma release assays (IGRA)

Detecting latent tuberculosis using interferon gamma release assays (IGRA) Detecting latent tuberculosis using interferon gamma release assays (IGRA) American Society for Microbiology June 2017 Edward Desmond, Ph.D., D (ABMM) San Lorenzo, CA Edward Desmond has no financial connections

More information

INSTRUCTOR S GUIDE VERSION

INSTRUCTOR S GUIDE VERSION EHS EXERCISE 1: Risk Assessment: A Case Study of an Investigation of a Tuberculosis (TB) Outbreak in a Health Care Setting Estimated Time to Complete in an Online Course or In-person Course Discussion:

More information

TB Program Management San Antonio, Texas November 5-7, 2008

TB Program Management San Antonio, Texas November 5-7, 2008 TB Program Management San Antonio, Texas November 5-7, 2008 Infection Control Lynelle Phillips, RN, MPH November 7, 2008 Infection Control Lynelle Phillips, RN MPH Nurse Consultant Heartland National TB

More information

RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS

RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS Southeast Asian J Trop Med Public Health RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS Benjawan Phetsuksiri 1, Somchai

More information

Rule out pulmonary tuberculosis: Clinical and radiographic clues for the internist

Rule out pulmonary tuberculosis: Clinical and radiographic clues for the internist REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will recognize the signs of and include it in the differential diagnosis in appropriate scenarios CATHERINE ANNE CURLEY, MD Division Director, Hospital

More information

Tuberculosis is the model of a disease that can only be

Tuberculosis is the model of a disease that can only be INVITED COMMENTARY The Race to Eliminate Tuberculosis Jason E. Stout Tuberculosis is a major cause of morbidity and mortality worldwide, but the number of cases is now lower than ever before, both in the

More information

JCM Version 3. Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the

JCM Version 3. Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the JCM Accepts, published online ahead of print on 23 June 2010 J. Clin. Microbiol. doi:10.1128/jcm.02253-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Albert Nienhaus 1,2* and José Torres Costa 3

Albert Nienhaus 1,2* and José Torres Costa 3 Nienhaus and Costa Journal of Occupational Medicine and Toxicology 2013, 8:1 RESEARCH Open Access Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-γ

More information

Literature Overview. Health Economics. Experience with QuantiFERON -TB Gold. Cellestis Clinical Guide series

Literature Overview. Health Economics. Experience with QuantiFERON -TB Gold. Cellestis Clinical Guide series Literature Overview Experience with QuantiFERON -TB Gold Health Economics Cellestis Clinical Guide series 2008 www.cellestis.com This literature overview is intended to provide healthcare professionals

More information

Journal of Infectious Diseases Advance Access published August 2, 2013

Journal of Infectious Diseases Advance Access published August 2, 2013 Journal of Infectious Diseases Advance Access published August 2, 2013 1 Reversion and Conversion of Interferon-gamma Release Assay Results in HIV-1 Infected Individuals Maximilian C. Aichelburg 1,*, Thomas

More information

Mycobacterium tuberculosis, the organism

Mycobacterium tuberculosis, the organism ARTICLE 4 An epidemiologic investigation of occupational transmission of Mycobacterium tuberculosis infection to dental health care personnel Infection prevention and control implications Jennifer L. Merte,

More information

The authors assessed drug susceptibility patterns

The authors assessed drug susceptibility patterns Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division

More information

Laboratory Reporting of Tuberculosis Test Results and Patient Treatment Initiation in California

Laboratory Reporting of Tuberculosis Test Results and Patient Treatment Initiation in California JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2004, p. 4209 4213 Vol. 42, No. 9 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.9.4209 4213.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Occupational Risk of Latent Tuberculosis Infection in Health Workers of 14 Military Hospitals

Occupational Risk of Latent Tuberculosis Infection in Health Workers of 14 Military Hospitals ORIGINAL ARTICLE Occupation & Environmental Medicine https://doi.org/10.3346/jkms.2017.32.8.1251 J Korean Med Sci 2017; 32: 1251-1257 Occupational Risk of Latent Tuberculosis Infection in Health Workers

More information

Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers

Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers REVIEW http://dx.doi.org/10.4046/trd.2016.79.3.127 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2016;79:127-133 Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers

More information

Do we know enough to prevent occupationally acquired tuberculosis in healthcare workers?

Do we know enough to prevent occupationally acquired tuberculosis in healthcare workers? REVIEW ARTICLE PEER REVIEWED Do we know enough to prevent occupationally acquired tuberculosis in healthcare workers? Muzimkhulu Zungu and Molebogeng Malotle, TB HIV in the workplace, National Institute

More information

The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers

The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers ORIGINAL ARTICLE The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers Masaki Tanabe 1, Akiko Nakamura 1, Akie Arai 1, Daisuke Yamasaki

More information

TB Infection Control. Carol Staton, RN, BSN March 17, TB Nurse Case Management March 17 19, 2015 San Antonio, Texas

TB Infection Control. Carol Staton, RN, BSN March 17, TB Nurse Case Management March 17 19, 2015 San Antonio, Texas TB Infection Control Carol Staton, RN, BSN March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Carol Staton, RN, BSN has the following disclosures

More information

LATENT TUBERCULOSIS SCREENING AND TREATMENT:

LATENT TUBERCULOSIS SCREENING AND TREATMENT: LATENT TUBERCULOSIS SCREENING AND TREATMENT: TB or not TB Christopher Kwong, MD and William Rifkin, MD Week 14 Educational Objectives: 1. Understand who should be screened for latent TB infection and why

More information

*Bamrasnaradura Infectious Diseases Institute, Nonthaburi 11000, Bangkok Hospital, Bangkok, Thailand. ABSTRACT

*Bamrasnaradura Infectious Diseases Institute, Nonthaburi 11000, Bangkok Hospital, Bangkok, Thailand. ABSTRACT OriginalArticle Isoniazid Prophylaxis of Latent Tuberculous Infection among Healthcare Workers in Bamrasnaradura Infectious Diseases Institute Patama Suttha, M.D.*, Pranom Noppakun, M.NS.*, Patchara Tanthirapat,

More information

Therapy for Latent Tuberculosis Infection

Therapy for Latent Tuberculosis Infection Screening and Treatment of LTBI in TB Control in the US Margarita Elsa Villarino MD MPH Division of TB Elimination, CDC April 14, 2004 TB Prevention and Control in the United States The fundamental strategies

More information

The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks

The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks ORIGINAL ARTICLE http://dx.doi.org/10.4046/trd.2015.78.4.349 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:349-355 The Prevalence Rate of Tuberculin Skin Test Positive by Contacts

More information

These recommendations will remain in effect until the national shortage of PPD solution has abated.

These recommendations will remain in effect until the national shortage of PPD solution has abated. Maryland Recommendations Regarding the National Shortage of Purified Protein Derivative (PPD) Solution; Attachment to Health Officer Memorandum National Shortages of Tubersol and Aplisol for TB Skin Testing;

More information

TB Infection Control. Delvina Mimi Ford, BSN, RN, CCRN-K, has the following disclosures to make:

TB Infection Control. Delvina Mimi Ford, BSN, RN, CCRN-K, has the following disclosures to make: TB Infection Control Delvina Mimi Ford, BSN, RN, CCRN-K September 7, 2016 TB Nurse Case Management September 7-9, 2016 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Delvina Mimi Ford, BSN, RN, CCRN-K,

More information

ORIGINAL INVESTIGATION. The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees

ORIGINAL INVESTIGATION. The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees ORIGINAL INVESTIGATION The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees Santiago Moreno, MD; Rosa Blázquez, MD; Abel Novoa, MD; Isabel Carpena, MD;

More information

Thorax Online First, published on December 8, 2009 as /thx

Thorax Online First, published on December 8, 2009 as /thx Thorax Online First, published on December 8, 2009 as 10.1136/thx.2009.119677 Title Page Cost effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the Quantiferon-TB gold

More information

Occupational Risk to Tuberculosis Disease among Health Care Workers in an Emergency Department Hospital

Occupational Risk to Tuberculosis Disease among Health Care Workers in an Emergency Department Hospital 2, Issue 1 (2018) 1-6 Journal of Advanced Research in Occupational Safety and Health Journal homepage: www.akademiabaru.com/arosh.html ISSN: 2637-0255 Occupational Risk to Tuberculosis Disease among Health

More information

TB Infection Control

TB Infection Control TB Infection Control Delvina Mimi Ford, BSN, RN, CCRN K March 7, 2017 TB Nurse Case Management March 7 9, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Delvina Mimi Ford, BSN, RN, CCRN K has the

More information

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB

More information

Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective

Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective James Watt, MD, MPH Acting Chief, Tuberculosis Control Branch California Department of Public

More information

TB Intensive San Antonio, Texas December 1-3, 2010

TB Intensive San Antonio, Texas December 1-3, 2010 TB Intensive San Antonio, Texas December 1-3, 2010 TB Pathogenesis and Transmission Lynn Horvath, MD; TCID December 1, 2010 Tuberculosis Pathogenesis Lynn L. Horvath, MD, FACP, FIDSA Associate Professor

More information

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Chapter 1 Overview of Tuberculosis Epidemiology in the United States Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United

More information

Tuberculosis outbreak among students in a boarding school

Tuberculosis outbreak among students in a boarding school Eur Respir J 2006; 28: 986 991 DOI: 10.1183/09031936.06.00002506 CopyrightßERS Journals Ltd 2006 Tuberculosis outbreak among students in a boarding school C. Stein-Zamir*, I. Volovik #, S. Rishpon ", A.

More information

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program Topics of Discussion TB Overview Epidemiology of TB in Oregon Annual Facility

More information

2013 Guidelines for Prevention and Control of Tuberculosis In California Long Term Health Care Facilities ( 2017:27: (07)

2013 Guidelines for Prevention and Control of Tuberculosis In California Long Term Health Care Facilities ( 2017:27: (07) 116 2013 1 2 2 1 3 4 5 6 7 8 9 2 10 11 2 12 13 14 15 15 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 2025 2013 Guidelines for Prevention and Control of Tuberculosis In California Long Term Health Care Facilities

More information

U.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults

U.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults Centers

More information

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment ORIGINAL ARTICLE Korean J Intern Med 217;32:32-38 https://doi.org/1.394/kjim.216.199 Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis

More information

TUBERCULOSIS INFECTION CONTROL PLAN

TUBERCULOSIS INFECTION CONTROL PLAN TUBERCULOSIS INFECTION CONTROL PLAN (TBICP) The Hamilton Eye Institute at The University of Tennessee 930 Madison Avenue Memphis, Tennessee 38163 The Hamilton Eye Institute at The University of Tennessee

More information

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges David Karol, MD, MA Bureau of Prisons, FMC Butner Duke University Medical Center June 26, 2013 No Disclosures

More information

Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-c release assay

Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-c release assay Eur Respir J 29; 34: 1423 1428 DOI: 1.1183/931936.5389 CopyrightßERS Journals Ltd 29 Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-c release

More information

HOME FOR THE AGED TB SCREENING STANDARDS FOR RESIDENTS & EMPLOYEES

HOME FOR THE AGED TB SCREENING STANDARDS FOR RESIDENTS & EMPLOYEES BCHS HOME FOR THE AGED TB SCREENING STANDARDS FOR RESIDENTS & EMPLOYEES C U S T O M E R D R I V E N. B U S I N E S S M I N D E D. Objectives What Is TB Symptoms of TB Public Health TB Screening strategy

More information

Weekly. August 8, 2003 / 52(31);

Weekly. August 8, 2003 / 52(31); Weekly August 8, 2003 / 52(31);735-739 Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis

More information

!"#$%&'()*+,-./01 !"#$ N! !"#$%&'()*+,- !"#$%&'()*+,-)*./01!"#$% &'()*+,-./#0!"#$#%

!#$%&'()*+,-./01 !#$ N! !#$%&'()*+,- !#$%&'()*+,-)*./01!#$% &'()*+,-./#0!#$#% !"#$%&!"#$ N!!"#$%&'()!" N!!"#$%&'()*+,-./0123456789:;4567 OMN!"#$%!&!"#$%&'!( )*+,-./01!2345678019:;?@!ABC%6 2!"#$%&'()*!+,,-./*012345-678*4509:;?@ABC./$! -.!/0123456*+!789:6;?@A2B!#$6CD

More information

Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation

Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation American Journal of Transplantation 2007; 7: 2797 2801 Blackwell Munksgaard C 2007 The Authors Journal compilation C 2007 The American Society of Transplantation and the American Society of Transplant

More information

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of Health and Mental Hygiene TODAY S PRESENTATION Epidemiology

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 Interferon Gamma Release Assays Lisa Armitige, MD, PhD November 12, 2014 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of

More information

The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea

The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea ORIGINAL ARTICLE https://doi.org/10.4046/trd.2018.0020 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2018;81:274-280 The Prevalence and Risk Factors of Latent Tuberculosis Infection among

More information

Tuberculosis in Pregnancy

Tuberculosis in Pregnancy Tuberculosis in Pregnancy 1. Screening for Latent Tuberculosis Infection (LTBI) WHO to screen? Those at high risk for contracting TB and converting from latent to active TB Known HIV infection Close contact

More information

Tuberculosis Epidemiology

Tuberculosis Epidemiology Tuberculosis Epidemiology TB CLINICAL INTENSIVE COURSE Curry International Tuberculosis Center October 18, 2017 Varsha Hampole, MPH Tuberculosis Control Branch California Department Of Public Health Outline

More information

Guidelines for TB contact tracing in Pacific Island countries and territories

Guidelines for TB contact tracing in Pacific Island countries and territories Guidelines for TB contact tracing in Pacific Island countries and territories Background Tuberculosis (TB) continues to be a public health issue of major significance around the world. The World Health

More information

Replaces: 02/11/16. Formulated: 7/95 EMPLOYEE TB TESTING

Replaces: 02/11/16. Formulated: 7/95 EMPLOYEE TB TESTING Effective : 02/09/17 Page 1 of 4 PURPOSE: To describe the process where by employees may obtain routine TB skin testing by facility medical staff. POLICY: Employees of the Texas Department of Criminal

More information

Diagnosis Latent Tuberculosis. Disclosures. Case

Diagnosis Latent Tuberculosis. Disclosures. Case Diagnosis Latent Tuberculosis Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention September 2016 1 Disclosures

More information

Table 9. Policy for Tuberculosis Surveillance and Screening

Table 9. Policy for Tuberculosis Surveillance and Screening Policy for Tuberculosis Surveillance and Screening Purpose: to identify active cases of tuberculosis or latent TB among residents and staff of the nursing home in order to prevent transmission in this

More information

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed

More information

TB Intensive Houston, Texas October 15-17, 2013

TB Intensive Houston, Texas October 15-17, 2013 TB Intensive Houston, Texas October 15-17, 2013 Interferon Gamma Release Assays (IGRA s) Lisa Armitige, MD, PhD October 16, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict

More information

Tsira Chakhaia 1 *, Matthew J. Magee 2,3, Russell R. Kempker 4, Medea Gegia 1, Leila Goginashvili 5, Ucha Nanava 5, Henry M. Blumberg 3,4.

Tsira Chakhaia 1 *, Matthew J. Magee 2,3, Russell R. Kempker 4, Medea Gegia 1, Leila Goginashvili 5, Ucha Nanava 5, Henry M. Blumberg 3,4. High Utility of Contact Investigation for Latent and Active Tuberculosis Case Detection among the Contacts: A Retrospective Cohort Study in Tbilisi, Georgia, 2010 2011 Tsira Chakhaia 1 *, Matthew J. Magee

More information

Vaccine Preventable Respiratory Infections and Tuberculosis

Vaccine Preventable Respiratory Infections and Tuberculosis Vaccine Preventable Respiratory Infections and Tuberculosis Infection Prevention Essentials in Long-Term Care Spring 2019 Teri Hulett, RN, BSN, CIC, FAPIC Leading infection prevention education across

More information

Global epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos

Global epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe

More information

Overview of the WHO policy on TB Infection Control and practical aspects and implementation tools for effective IC measures in Health facilities

Overview of the WHO policy on TB Infection Control and practical aspects and implementation tools for effective IC measures in Health facilities Overview of the WHO policy on TB Infection Control and practical aspects and implementation tools for effective IC measures in Health facilities Dr. M. Angélica Salomão Medical Officer DOTS Expansion &

More information

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Interferon Gamma Release Assays: Understanding the Test David Griffith, BA, MD April 11, 2014 David Griffith, BA, MD has the following

More information

Biomed Environ Sci, 2015; 28(8):

Biomed Environ Sci, 2015; 28(8): Biomed Environ Sci, 2015; 28(8): 611-615 611 Letter to the Editor The Impact of Directly Observed Therapy on Preventive Treatment for Latent Tuberculosis Infection among Students in Dalian, China CHEN

More information

!"#$%&'()*+,-./0. An Empirical Analysis of Cognitive Behavior Group Therapy in Patients with Depression G GG

!#$%&'()*+,-./0. An Empirical Analysis of Cognitive Behavior Group Therapy in Patients with Depression G GG !"#$%&'( NV!"#$%&'()*+,-./0 An Empirical Analysis of Cognitive Behavior Group Therapy in Patients with Depression G GG 56789:;,-?@ABCDEFGHIJ 56789:;?@A$%BC%D/E!FGH 56789:9;#$&':?@AB;(7CD!"#$%&'()*+,-.+/01234567%&89+,:;+,+?0@ABCDE!"#$%&'()*+,-./0123./45678./9:;?!@ABCD!E!"#$%&'()*+,-./(0123456789:;?@ABCD:;EFGH!"#$E!"#I=2004;

More information

Occupational tuberculosis: a review of the literature and the local situation

Occupational tuberculosis: a review of the literature and the local situation REVIEW ARTICLE CME CM Tam CC Leung Occupational tuberculosis: a review of the literature and the local situation!"#$%&'()*+,-./0 Objective. To review the risks and control of occupation-related tuberculosis.

More information

TB in California: Costs, Transmission, and Selecting from the Latent Pool

TB in California: Costs, Transmission, and Selecting from the Latent Pool TB in California: Costs, Transmission, and Selecting from the Latent Pool Pennan Barry, MD, MPH Tuberculosis Control Branch California Department of Public Health California Tuberculosis Controller s Association

More information

Coordinating with Public Health on Tuberculosis Testing & Treatment

Coordinating with Public Health on Tuberculosis Testing & Treatment Coordinating with Public Health on Tuberculosis Testing & Treatment Bernadette Jakeman, PharmD, PhC, BCPS, AAHIVP Associate Professor University of New Mexico College of Pharmacy Objectives 1. Identify

More information

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children 616 TUBERCULOSIS Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children T G Connell*, N Curtis*, S C Ranganathan, J P Buttery...

More information

Time interval to conversion of interferon-c release assay after exposure to tuberculosis

Time interval to conversion of interferon-c release assay after exposure to tuberculosis Eur Respir J 2011; 37: 1447 1452 DOI: 10.1183/09031936.00089510 CopyrightßERS 2011 Time interval to conversion of interferon-c release assay after exposure to tuberculosis S.W. Lee*,#, D.K. Oh ", S.H.

More information

Nursing and Community Rates of Mycobacterium tuberculosis Infection among Students in Harare, Zimbabwe

Nursing and Community Rates of Mycobacterium tuberculosis Infection among Students in Harare, Zimbabwe MAJOR ARTICLE Nursing and Community Rates of Mycobacterium tuberculosis Infection among Students in Harare, Zimbabwe Elizabeth L. Corbett, 1,2 Joyce Muzangwa, 2 Kathryn Chaka, 2 Ethel Dauya, 2 Yin Bun

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

August 30, 1991 / 40(34);

August 30, 1991 / 40(34); August 30, 1991 / 40(34);585-591 Epidemiologic Notes and Reports Nosocomial Transmission of Multidrug-Resistant Tuberculosis Among HIV-Infected Persons -- Florida and New York, 1988-1991 During 1990 and

More information

TB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010

TB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010 TB Infection Who is Testing and Treating? Jennifer Flood, M.D., M.P.H. California Department of Public Health Tuberculosis Control Branch Jennifer.Flood@cdph.ca.gov 1 TB Control and Elimination: Current

More information

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening

More information

Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection

Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Krista Powell, MD, MPH Co-Project Officer, National Surveillance for Severe Adverse Events Associated with LTBI Treatment Lead,

More information

Community pharmacy-based tuberculosis skin testing

Community pharmacy-based tuberculosis skin testing Community pharmacy-based tuberculosis skin testing Shanna K. O Connor, PharmD ISU KDHS Spring CE Seminar 2018 In support of improving patient care, Idaho State University Kasiska Division of Health Sciences

More information

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Co-morbidities in Substance Abuse that Impact Managing TB Lisa Armitige, MD, PhD April 27, 2011 Lisa Armitige, MD, PhD has the following

More information

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016 Learning Objectives Tuberculosis Case Discussions: Evaluation for Tuberculosis Infection Melissa C. Overman, DO, MPH, CHES, FAOCOPM Describe appropriate technique for TST placement, reading and interpretation

More information

Who is at Risk of TB?

Who is at Risk of TB? Who is at Risk of TB? Lisa Armitige, MD, PhD September 20, 2017 Screening for Tuberculosis Infection September 20, 2017 Harlingen, TX EXCELLENCE EXPERTISE INNOVATION Lisa Armitige, MD, PhD has the following

More information

=!"#$%& !"#$%&'( )*+,-. !"#$%&'

=!#$%& !#$%&'( )*+,-. !#$%&' =!"#$%&!"#$%&'()*+,-.!"#$%&'!"#$%&'()*+$%,-./0$%&12'3456789:;?@&ABCDEF!"#$%&'()*+,-./0123456789%&'$:;?$@AB:CDE1FGH!"#$%&'()*+,-./0123456789:;?@0ABCDEAF GHICJK!"#$%&'()*+,-./#$0123%&!456789:;?@A,0BCD6E4!"#$%&'()*+,-./0123456()*/789

More information

Decreasing tuberculosis morbidity in the United

Decreasing tuberculosis morbidity in the United Acceptability of Short-Course Rifampin and Pyrazinamide Treatment of Latent Tuberculosis Infection Among Jail Inmates* Naomi N. Bock, MD; Tara Rogers, BS; Jane R. Tapia, RN; George D. Herron, MHA; Beverly

More information

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017 Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has

More information

Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?

Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? Journal of Antimicrobial Chemotherapy (27) 59, 794 798 doi:.93/jac/dkm25 Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? Jesús

More information

Tuberculosis outbreak among students in a

Tuberculosis outbreak among students in a ERJ Express. Published on June 28, 2006 as doi: 10.1183/09031936.06.00002506 Tuberculosis outbreak among students in a boarding school Chen Stein-Zamir 1 MD MPH, Irina Volovik 2 MD MPH, Shmuel Rishpon

More information

Development of CDC s Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care

Development of CDC s Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care Development of CDC s Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care Michele Junger, DDS, MPH Division of Oral Health OSAP June 3, 2016 National Center for

More information

APSR RESPIRATORY UPDATES

APSR RESPIRATORY UPDATES APSR RESPIRATORY UPDATES Volume 5, Issue 2 Newsletter Date: February 2013 APSR EDUCATION PUBLICATION Inside this issue: Tuberculosis Multidrug-resistant pulmonary tuberculosis treatment regimens and patient

More information

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.

More information

Healthcare workers (HCWs) are at risk of. Healthcare workers with tuberculosis infected during work

Healthcare workers (HCWs) are at risk of. Healthcare workers with tuberculosis infected during work Eur Respir J 2006; 28: 1216 1221 DOI: 10.1183/09031936.06.00039906 CopyrightßERS Journals Ltd 2006 Healthcare workers with tuberculosis infected during work G. de Vries*,#, M.M.G.G. Šebek " and C.S.B.

More information

Enhancement of Treatment Completion for Latent Tuberculosis Infection With 4 Months of Rifampin*

Enhancement of Treatment Completion for Latent Tuberculosis Infection With 4 Months of Rifampin* CHEST Enhancement of Treatment Completion for Latent Tuberculosis Infection With 4 Months of Rifampin* Alfred Lardizabal, MD; Marian Passannante, PhD; Faysal Kojakali, MPH; Christopher Hayden, BA; and

More information

Guidelines for TB Infection Control in High-HIV HIV Burden Settings

Guidelines for TB Infection Control in High-HIV HIV Burden Settings Guidelines for TB Infection Control in High-HIV HIV Burden Settings Paul A. Jensen, PhD, PE Centers for Disease Control and Prevention Coordinating Center for Infectious Diseases National Center for HIV,

More information

Updated Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel, United States, 2018

Updated Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel, United States, 2018 Updated Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel, United States, 2018 Lynn Sosa, MD Bob Belknap, MD Healthcare Worker Screening Guidelines Working Group Healthcare

More information

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Historically, Latent Tuberculosis Infection (LTBI) diagnosis was based on risk assessment, chest x-ray (CXR)

More information

Hypoalbuminemia and Lymphocytopenia are Predictive Risk Factors for In-hospital Mortality in Patients with Tuberculosis

Hypoalbuminemia and Lymphocytopenia are Predictive Risk Factors for In-hospital Mortality in Patients with Tuberculosis ORIGINAL ARTICLE Hypoalbuminemia and Lymphocytopenia are Predictive Risk Factors for In-hospital Mortality in Patients with Tuberculosis Kyoko Okamura 1,4, Nobuhiko Nagata 2, Kentaro Wakamatsu 1, Koji

More information